Purpose Activated coagulation and fibrinolytic system in cancer patients is associated with
tumor stroma formation and metastasis in different cancer types. The aim of this study is to …

Objectives: Activation of coagulation and fibrinolysis is frequently observed in patients with
cancer, even with absence of thrombosis. Furthermore, plasma coagulation parameters …

Activated coagulation and fibrinolytic system in cancer patients is associated with tumor
stroma formation and metastasis in different cancer types. The aim of this study is to explore …

Background and objectives: Cancer coagulopathy is thought to be partially due to the up-
regulation of tissue factor (TF), thrombin-antithrombin complex (TAT) and soluble P-selectin …

Purpose Activation of coagulation and fibrinolysis is frequently found among cancer patients.
Such tumors are considered to be associated with a higher risk of invasion, metastases, and …

Aberrant factors associated with fibrinolysis and thrombosis are found in many cancer
patients, which can promote metastasis and are associated with poor prognosis. The …

Background We sought to investigate the efficacy of serum D-dimer, fibrinogen, and CA19-9
for postoperative monitoring and prediction of survival in patients with resectable pancreatic …

Introduction: Recent experimental studies have suggested that various coagulation-related
molecules may be important players in the development and progression of pancreatic …

Cancer patients frequently present with activated coagulation pathways and thrombocytosis,
which are potentially associated with tumor progression and prognosis. However, the …

Background. To elucidate the disturbed hemostatic balance in patients with pancreatic
cancer, the levels of plasma coagulation inhibition and coagulation activation were …